• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles

Chemical Profile of (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic Acid (CAS No. 1418007-47-2)

(2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid, identified by its CAS number 1418007-47-2, is a compound of significant interest in the field of chemical and pharmaceutical research. This molecule, featuring a conjugated system with a thiazole ring, has garnered attention due to its potential biological activities and structural properties that make it a valuable scaffold for drug development.

The structure of (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid consists of an alpha,beta-unsaturated carboxylic acid moiety linked to a thiazole ring. This configuration suggests possible applications in the synthesis of heterocyclic compounds, which are widely recognized for their role in medicinal chemistry. The presence of the thiazole ring, a well-known pharmacophore, enhances the compound's versatility in interactions with biological targets.

Recent research has highlighted the importance of thiazole derivatives in pharmaceutical applications. Studies have demonstrated that compounds incorporating thiazole moieties often exhibit desirable pharmacological properties, including antimicrobial, anti-inflammatory, and anticancer effects. The specific arrangement of atoms in (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid positions it as a promising candidate for further investigation in these areas.

In particular, the conjugated double bond system in (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid may contribute to its ability to interact with biological molecules through both hydrophobic and electrostatic interactions. This feature is particularly relevant in drug design, where optimizing such interactions can lead to improved binding affinity and efficacy.

The synthesis of (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid involves multi-step organic reactions that require careful consideration of reaction conditions and reagent selection. Advanced synthetic techniques, such as cross-coupling reactions and palladium catalysis, have been employed to achieve high yields and purity. These methods are essential for ensuring that the final product meets the stringent requirements of pharmaceutical research.

One of the most compelling aspects of (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid is its potential as a building block for more complex drug candidates. By modifying its structure or incorporating additional functional groups, researchers can explore new pharmacological profiles and therapeutic applications. For instance, derivatives of this compound have been investigated for their role in modulating enzyme activity and inhibiting pathological pathways associated with various diseases.

The use of computational methods has also played a crucial role in understanding the properties of (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid. Molecular modeling techniques allow researchers to predict how this compound might behave in different environments and how it might interact with biological targets. These predictions can guide experimental design and help identify promising leads for further development.

In conclusion, (2E)-3-(1,3-thiazol-5-yl)prop-2-enoic acid (CAS No. 1418007-47-2) represents a significant advancement in pharmaceutical chemistry. Its unique structure and potential biological activities make it a valuable asset for researchers working on new drug development. As our understanding of molecular interactions continues to grow, compounds like this one will undoubtedly play an increasingly important role in addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)